Ask AI

Capsule Summaries


Share

Program Content

Activities

EMBRACE: N6LS Safety and Tolerability
EMBRACE: Safety and Tolerability of VH3810109 (N6LS) in People With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 22, 2025

CLARITY
CLARITY: Comparison of Long-Acting Injectable Antiretrovirals in Healthy Adults Without HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 22, 2025

PURPOSE 2 Subanalysis
PURPOSE 2 Subanalysis: Annual Persistence on Twice-Yearly LEN vs Daily FTC/TDF for PrEP Among Cisgender Men and Gender-Diverse People
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 22, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare